A route of administration is a way that a drug can enter the body. There are many drug routes of administration, each suited to different situations. Each route has its benefits and potential risks.

"Submitting romosozumab for marketing approval in Japan is an important milestone in our global development program with UCB and our strategic alliance with Astellas Pharma," said Sean E. Harper, M.D.

AUSTIN, Texas – One year of romosozumab (Evenity) followed by 1 year of denosumab (Prolia, Xgeva) was associated with improved bone mineral density (BMD) and lower fracture incidence compared with 2 ...

Romosozumab is contraindicated in patients with previous myocardial infarction or stroke. When determining whether to use romosozumab for an individual patient, consideration should be given to her ...

Romosozumab significantly increased bone mineral density (BMD) in postmenopausal women with severe osteoporosis after 6 and 12 months, irrespective of prior exposure to bisphosphonates, with over half ...